![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Clinical Predictors of Liver Fibrosis
Presence and Progression in
HIV-Associated Nonalcoholic Fatty Liver Disease
|
|
|
CROI 2020 March 11
Reported by Jules Levin
Lindsay T. Fourman1, Takara L. Stanley1, Meghan Feldpausch 1,
Julia Purdy 2, Isabel Zheng 1, Chelsea S. Pan 1, Julia Aepfelbacher 2,
Colleen Buckless 3, Andrew Tsao 3, Kathleen E. Corey 4,
Raymond T. Chung 4, Martin Torriani 3, David E. Kleiner 5,
Colleen Hadigan 2, and Steven K. Grinspoon1
1 Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA
2 National Institute of Allergy and Infectious Disease, NIH, Bethesda, MD
3 Dept of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA
4 Liver Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA
5 Laboratory of Pathology, National Cancer Institute, NIH, Bethesda, MD
![0323201](../images/032320/032320-3/0323201.gif)
![0323202](../images/032320/032320-3/0323202.gif)
![0323203](../images/032320/032320-3/0323203.gif)
![0323204](../images/032320/032320-3/0323204.gif)
![0323205](../images/032320/032320-3/0323205.gif)
![0323206](../images/032320/032320-3/0323206.gif)
![0323207](../images/032320/032320-3/0323207.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|